We are a South African pharmaceutical company established in 2020, bringing new medicines and biological medicines to the local market.
Biomab is a pharmaceutical company that is committed to providing faster and broader access to innovation for patients in South Africa.
Biomab has an industry leading specialist team of representatives and medical personnel with national reach. Our team has established relationships with customers in both the Public and Private sectors. We actively call on practitioners in the spheres of Oncology, Haematology, General and Specialised Medicine.
We presently market products for Roche, Bayer and Helsinn.
Biomab’s expertise in the pharmaceutical industry, including our highly trained national representative team, regulatory department, pharmacovigilance team and quality assurance department, allows us to expand the range of multinational innovator products in the region.
Biomab is your partner in expanding access to innovative medicines. Whether you’re a patient, healthcare provider, or industry stakeholder, we’re here to make a difference.